Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Inozyme Pharma Expands its Scientific Advisory Board
Inozyme Pharma Inc.April 1, 2021 GMT
BOSTON, April 01, 2021 (GLOBE NEWSWIRE) Inozyme Pharma, Inc., a rare disease biopharmaceutical company developing novel therapeutics for the treatment of disorders of abnormal mineralization, announced today changes to its scientific advisory board (SAB), including the addition of three leading key opinion leaders with specific expertise in the company’s lead indications:
W Charles O’Neill IV, M.D., Director of the Ultrasonography Program in the Renal Division at Emory University School of Medicine
Provided
Members of the Black Graduate and Professional Student Association attend the group’s annual Renaissance Ball in 2019. Students, alumni celebrate Black graduate excellence
February 25, 2021
Earning a doctorate involves years of long days and dead ends, but finding a community can smooth the path. For several alumni, joining the Black Graduate and Professional Student Association (BGPSA) helped pave the way to success at Cornell and beyond.
“Celebrating Black Graduate Excellence at Cornell,” a two-day series of alumni-filled panels, honored the contributions of Black graduate students, the BGPSA and its members – including the Renaissance Ball they founded.
Since they couldn’t gather in person for the Renaissance Ball, the Graduate and Professional Student Diversity Council and the Graduate School Office of Inclusion and Student Engagement celebrated over Zoom with discussions about the BGPSA’s history and legacy and the Black graduate student ex
Philadelphia Man Becomes First Black Acceptant Into Groundbreaking Biotech Graduate Program at His University
Nafees Norris is on winter break.
The 26-year-old Philadelphia native just completed his first semester of graduate studies at Thomas Jefferson University.
But Norris is not just any student. And the Jefferson Institute of Bioprocessing (JIB) is not just any master’s course. The hybrid program opened in May 2019, becoming North America’s first specialized training institute for biopharmaceutical processing.
Norris became the first Black person accepted into the 12-month accelerated master’s program.
Biopharmaceutical processing is a rapidly expanding industry. Students in the JIB program learn gene therapy, protein replacement therapy and how to create vaccinations for pathogens such as COVID-19.